Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase [Phase 4]
This clinical trial update describes a Phase 4 study evaluating levofloxacin prophylaxis to prevent the first febrile neutropenia during ind…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Dietary Intake, Sarcopenic Obesity, and Other Treatment-Related Outcomes in Indian Children With Acute Lymphoblastic Leukemia
A ClinicalTrials.gov update on dietary intake, sarcopenic obesity, and other treatment-related outcomes in Indian children with acute lympho…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Pharmacokinetics of Drugs Administered to Children
This clinical trial update outlines ongoing pharmacokinetic studies of drugs administered to children with acute lymphoblastic leukemia.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia [NA]
This clinical trial update assesses the preliminary effectiveness and feasibility of transcutaneous acupoints electrical stimulation for che…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) [NA]
A completed clinical trial update reporting long-term outcomes of alternative donor allogeneic transplantation across multiple hematologic d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN) [Phase 1]
Phase 1 trial evaluating activated T cells expressing second- or third-generation CD19-directed CAR-T cells in advanced B-cell malignancies.…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma [NA]
This clinical trial update describes a non-pharmacologic High-Intensity Parent Intervention Program aimed at improving learning and school f…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy [NA]
Clinical trial update describing a study evaluating acute and chronic nephrotoxicity in patients with acute lymphoblastic leukemia using ult…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse [NA]
A clinical trial update describing a study on the role of CD9 gene regulation in relapse for pediatric acute lymphoblastic leukemia, current…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Besponsa Post Marketing Surveillance Study
A post-marketing surveillance study of Besponsa (inotuzumab ozogamicin) by Pfizer has completed, with results posted.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML
Recruiting study evaluating multiparametric flow cytometry to detect leukemia stem cells in peripheral blood and bone marrow to predict rela…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies [EARLY_Phase 1]
This clinical trial update describes an early-phase (Phase 1) study of LV009 injection for relapsed/refractory CD19-positive hematologic and…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation [NA]
A clinical trial is evaluating the safety and feasibility of sulforaphane to promote early hematopoietic recovery after cord blood transplan…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: CAV Regimen for R/R Ph- B-ALL [NA]
A clinical trial update for a CAV regimen in relapsed/refractory Philadelphia-negative B-ALL, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients [Phase 2]
A Phase 2 clinical trial update notes BEBT-908 plus chemotherapy for CR MRD-positive MEF2D-rearranged and pre-B acute lymphoblastic leukemia…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia [Phase 1]
This clinical trial update reports a Phase 1 study of CD19-directed allogeneic memory T-cell therapy for relapsed or refractory acute lympho…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia [NA]
A clinical trial evaluating a mobile health tool to help adolescents and young adults with acute lymphoblastic leukemia and lymphoblastic ly…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment [Phase 1]
Phase 1 pharmacokinetic study evaluating how hepatic impairment affects Olverembatinib exposure, to inform dosing in patients with liver dys…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome [Phase 3]
A Phase 3 clinical trial comparing mismatched related donor versus matched unrelated donor stem cell transplantation in children, adolescent…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia [Phase 1]
Phase Ib trial evaluating subcutaneous blinatumomab in combination with revumenib for KMT2A-rearranged acute lymphoblastic leukemia; the stu…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL [Phase 2, Phase 3]
This study outlines a framework to optimize, refine, and unify management of hematopoietic stem cell transplantation in pediatric acute lymp…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia [Phase 1, Phase 2]
Clinical trial update for 211At-BC8-B10 given before donor stem cell transplant in high-risk acute myeloid leukemia, acute lymphoblastic leu…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Validation of the ANI in Perpubescent Patients in Pediatric Intensive Care Unit.
A completed clinical trial validating the Analgesia/Nociception Index (ANI) in prepubescent patients in a pediatric intensive care unit.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: CAYA Cancer Retrospective Cohort Study
An ongoing retrospective cohort study titled CAYA Cancer, sponsored by Resonance, Inc., is currently recruiting to study Acute Lymphoblastic…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of inotuzumab ozogamicin in combination chemotherapy for acute lymphoblastic leukemia…